載入...
The MitoNEET Ligand NL-1 Mediates Antileukemic Activity in Drug-Resistant B-Cell Acute Lymphoblastic Leukemia
Disease relapse in B-cell acute lymphoblastic leukemia (ALL), either due to development of acquired resistance after therapy or because of de novo resistance, remains a therapeutic challenge. In the present study, we have developed a cytarabine (Ara-C)-resistant REH cell line (REH/Ara-C) as a chemor...
Na minha lista:
| 發表在: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6538890/ https://ncbi.nlm.nih.gov/pubmed/31010844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.118.255984 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|